MabVax Therapeutics Board Of Directors Authorizes The Company To Explore Strategic Alternatives Post author:Sam Post published:July 23, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like AstraZeneca PLC Loses $10 Billion in Value as Long-Awaited MYSTIC Trial Disappoints July 26, 2017 The Battle Between Two $1B+ Biotech Unicorns November 5, 2017 FDA Calls AstraZeneca PLC and MedImmune???s Imfinzi a Breakthrough July 30, 2017